By Fineline Cube 
Menarini Group, the Italian pharmaceutical company, and the Shanghai Angel Baby Charity Foundation have officially launched a comprehensive three-year public welfare initiative focused on treatment and scar care for children following injuries. The partnership will provide special assistance for emergency rescue of children from impoverished families suffering from burns, scalds, and accidental injuries across multiple regions in China.
Partnership Framework
| Component | Details |
|---|---|
| Duration | Three-year project cycle (2026–2029) |
| Geographic Scope | Multiple hospitals across various regions in China |
| Target Beneficiaries | Disadvantaged children requiring emergency rescue for burns, scalds, and trauma |
| Corporate Contribution | Menarini donation for emergency medical support and related public welfare activities |
| Foundation Partner | Shanghai Angel Baby Charity Foundation (established 2015) |
Strategic Integration of Corporate Expertise
- Product Integration: Menarini extends its professional expertise with Dermatix Ultra Gel in scar management from product support to comprehensive public welfare collaboration
- Long-term Commitment: Shift from transactional donations to sustained, practical actions addressing pediatric scar care needs
- Social Impact Goal: Drive broader social attention to the often-overlooked issue of pediatric scar care and rehabilitation
- Holistic Approach: Combines immediate emergency rescue support with longer-term scar management and care initiatives
Foundation Track Record & Network
- Children Assisted: 2,246 children with accidental injuries since foundation establishment in 2015
- Hospital Network: Deep cooperative relationships with more than 200 top-tier hospitals across China
- Emergency Infrastructure: Established “emergency green channels” for rapid response to children with accidental injuries
- Comprehensive Programs: Prevention education, emergency care, and ongoing support activities
Market & CSR Implications
- Pharmaceutical CSR Trend: Represents growing emphasis among multinational pharmaceutical companies on integrating core therapeutic expertise into corporate social responsibility initiatives
- Brand Enhancement: Menarini leverages its dermatological expertise to create authentic social impact while strengthening brand presence in the Chinese market
- Healthcare Access: Addresses critical gaps in emergency care access for economically disadvantaged families facing pediatric trauma
- Industry Leadership: Sets precedent for other pharmaceutical companies to move beyond traditional donation models toward expertise-driven public welfare partnerships
Forward‑Looking Statements
This brief contains forward-looking statements regarding the scope, duration, and expected impact of the Menarini-Angel Baby Foundation partnership. Actual outcomes may vary based on implementation factors, regulatory considerations, and evolving healthcare needs.-Fineline Info & Tech